IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies...
Transcript of IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies...
![Page 1: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/1.jpg)
Mogens VybergProfessor of Clinical PathologyDirector of NordiQCAalborg University Hospital, Aalborg, Denmark
IHC Classification of undifferentiated tumors –
the primary panel
![Page 2: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/2.jpg)
Tumours of unknown origin: Histology
Brain tumour - biopsy
![Page 3: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/3.jpg)
Tumours of unknown origin: Immunohistochemistry
Pan-CK S-100
CD45 VIM
![Page 4: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/4.jpg)
UPT: A tumour appearing in metastatic setting without a histologically proven primary tumour.
UPT pose an increasing challenge for the pathologist - due to the progress in surgical and oncological treatment possibilities.
IHC classification of the Unknown Primary Tumour
![Page 5: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/5.jpg)
New, relatively specific antibodies give the pathologist more and better diagnostic tools.
But the diagnostic work also become more complex in terms of planning, optimization of protocols, interpretation of reaction patterns and error trapping.
IHC classification of the Unknown Primary Tumour
![Page 6: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/6.jpg)
10 - 15% of cancers remained UPTs+ ??% uncertain if primary or metastatic
- liver, lung, bone, lymph nodes, brain, peritoneum . . .
‘Undifferentiated’ neoplasms (5-10%)- carcinomas, sarcomas, melanomas, germ cell tumours- malignant lymphomas
• Adenocarcinomas (80-90%)- lung, breast, prostate, colorectum, ovary, pancreas …
• Squamous cell carcinomas (5-10%)- lung, esophagus, uterine cervix …
IHC classification of the Unknown Primary Tumour
![Page 7: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/7.jpg)
Differences in prognosisDifferences in treatment regimes
malignant lymphomascarcinomas (breast, prostate, ovary . . .)sarcomas (GIST, synovial sarcoma . . .)
germ cell tumours
Pathology tests cost effectivePathology tests save patient discomfortThe patient’s ‘right to know’The risk of hereditary cancer
IHC classification of the Unknown Primary Tumour
![Page 8: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/8.jpg)
Most likely diagnoses
Relevant differential diagnoses
Optimal selection of antibodies for
a diagnostic algorithm Primary and secondary antibody panels
Turn-around-time
Laboratory expenses
IHC classification of the Unknown Primary Tumour
![Page 9: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/9.jpg)
Pathologist- knowledge, acceptance, skill
Tumour material- diagnostic markersAntibodies available- applic. in diagnostic algorithmsMethods- protocol:
sensitivity, specificity, reliability- interpretation:
cut-off level for positivityclinical relevance
GIST: S-100B Protease
GIST: S-100B MWO
IHC classification of the Unknown Primary Tumour
![Page 10: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/10.jpg)
CK 20
CK 20
positive = any staining
negative = < 50% stained cells
Pathologist- knowledge, acceptance, skill
Tumour material- diagnostic markersAntibodies available- applic. in diagnostic algorithmsMethods- protocol:
sensitivity, specificity, reliability- interpretation:
cut-off level for positivityclinical relevance
IHC classification of the Unknown Primary Tumour
![Page 11: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/11.jpg)
![Page 12: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/12.jpg)
![Page 13: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/13.jpg)
www.e-immunohistochemistry.info
Planning diagnostic immunohistochemistry
![Page 14: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/14.jpg)
Planning diagnostic immunohistochemistry
![Page 15: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/15.jpg)
Planning diagnostic immunohistochemistry
![Page 16: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/16.jpg)
![Page 17: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/17.jpg)
my.statdxpathiq.com
![Page 18: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/18.jpg)
![Page 19: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/19.jpg)
![Page 20: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/20.jpg)
![Page 21: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/21.jpg)
![Page 22: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/22.jpg)
![Page 23: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/23.jpg)
![Page 24: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/24.jpg)
?
?
?
?
?
![Page 25: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/25.jpg)
Primary panel for the unknown primary tumour
”Real” CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 26: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/26.jpg)
CD45 - Leucocyte common antigen (LCA)
• Transmembrane protein tyrosin phospatase essential for haematopoietic signal transduction and cell activation
• Membrane associated component: 5 isotypes• Intracellular component: one common type
![Page 27: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/27.jpg)
CD45 - Leucocyte common antigen (LCA)
• Transmembrane protein tyrosin phospatase essential for haematopoietic signal transduction and cell activation
• Membrane associated component: 5 isotypes• Intracellular component: one common type
• Large majority of haematolymphoid cells• Lost in maturing erythocytes, megakaryocytes and plasmacells• ”Never” found in non-haematolymphoid cells
![Page 28: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/28.jpg)
CD45 - Leucocyte common antigen (LCA)
Normal lymph node Malignant lymphoma
![Page 29: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/29.jpg)
CD45 - Leucocyte common antigen (LCA)
Liver Brain
Critical assay performance control
![Page 30: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/30.jpg)
www.nordiqc.org/Run-15/Assessment/assessment-CD45.htm
CD45 – NordiQC run 37 2013
Which is best?
![Page 31: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/31.jpg)
www.nordiqc.org/Run-15/Assessment/assessment-CD45.htm
CD45 – NordiQC run 37 2013
Optimal Insufficient
![Page 32: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/32.jpg)
www.nordiqc.org/Run-15/Assessment/assessment-CD45.htm
CD45 – NordiQC run 37 2013
Optimal Insufficient
B-CLL
56% of labs 18% of labs
![Page 33: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/33.jpg)
CD45 - Leucocyte common antigen (LCA)
Lymph node/Tonsil
CD45 RO ~ T-cells
CD45 RA ~ B-cells
![Page 34: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/34.jpg)
CD45 - Leucocyte common antigen (LCA)
![Page 35: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/35.jpg)
CD45 - Leucocyte common antigen (LCA)
![Page 36: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/36.jpg)
CD45 - Leucocyte common antigen (LCA)
![Page 37: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/37.jpg)
Primary panel for the unknown primary tumour
CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 38: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/38.jpg)
Cellular filaments
# Microfilaments: (6 nm)
# Intermediate filaments (7- 11 nm)
# Microtubuli (23 nm)
![Page 39: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/39.jpg)
Intermediate filaments
Group of mainly cytoplasmic filaments 7 – 11 nm in diameter Part of the cytoskeleton in virtually all cells, creating as meshwork and connecting nuclear membrane with cell membrane Often associated with microfilaments (6 nm) and microtubules (23 nm) Important for mechanical strength and cellular functions
![Page 40: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/40.jpg)
Intermediate filaments – tetrameric units
Central core formed by eight tetramers
Nagle, AJSP 1988, 12:4
![Page 41: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/41.jpg)
Intermediate filaments - 5 classes
I acidic cytokeratinsII basic-neutral cytokeratinsIII vimentin, desmin, glial fibrillary acidic protein, peripherinIV neurofilament protein, α-internexin, nestinV lamins
![Page 42: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/42.jpg)
Cytokeratins as tonofilaments
Drochmans et al. J Cell Biol. 1978, 79:427
Cytokeratin intermediate filaments attached to desmosomes
![Page 43: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/43.jpg)
Cytokeratins (CKs) belong to the most fundamental markers of epithelial differentiation CKs comprise a large family of subtypes. Different cell types express different patterns of CK subtypes Cancers generally express CK patterns that at least in part represent the pattern of the putative cell of origin Metastases express CK patterns fairly concordant with those of the primary tumours
Cytokeratins in diagnostic pathology
![Page 44: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/44.jpg)
HE CK
Micrometastases identified by cytokeratin
![Page 45: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/45.jpg)
Carcinoma in frosen section identified by cytokeratin
HE-frys CK-frys
![Page 46: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/46.jpg)
Low molecular weight cytokeratins in carcinomas
CK: renal cell carcinoma
Carcinomas “always” LMW-CK-positive, except some cases of Renal cell carcinomaAdrenal cortical carcinomaSmall cell carcinoma
CK8: Adrenal cortical carcinoma CK8: Renal cell carcinoma
![Page 47: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/47.jpg)
Primary panel for the unknown primary tumour
CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 48: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/48.jpg)
CK8 CD20 & CD3
♀ 42 y, tumour infiltrating retroperitoneum
CD45 & CD79a
Cytokeratins in non-epithelial tumours
Malignant lymphoma !
![Page 49: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/49.jpg)
Primary panel for the unknown primary tumour
CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 50: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/50.jpg)
Cytokeratins in malignant mesothelioma
CK8 CK5
![Page 51: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/51.jpg)
Primary panel for the unknown primary tumour
CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 52: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/52.jpg)
Cytokeratins in sarcomas
angiosarcomaSynovial sarcoma
![Page 53: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/53.jpg)
Leiomyosarcoma
Cytokeratins in non-epithelial tumours
![Page 54: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/54.jpg)
Primary panel for the unknown primary tumour
CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 55: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/55.jpg)
Cytokeratins in malignant melanoma
CK
![Page 56: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/56.jpg)
Primary panel for the unknown primary tumour
CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 57: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/57.jpg)
Cytokeratins in germ cell tumours
CK8: Seminoma CK8: Embr. carcinoma
![Page 58: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/58.jpg)
CK: renal cell carcinoma
HIER Proteolysis
AE1 detects CK8 after HIER onlyAE1 does not detect CK18AE3 does not detect CK8/CK18
Proteolysis
Cytokeratins: retrieval causing false negativity
SCLC
![Page 59: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/59.jpg)
CK: renal cell carcinoma
Cytokeratins: retrieval causing false negativity
RCC
FNTP
HIER Proteolysis
FNTP
![Page 60: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/60.jpg)
Primary panel for the unknown primary tumour
CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 61: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/61.jpg)
S-100 protein
Family of acid calcium binding proteins 9/13 kDa Located in nuclei, cytoplasm and cell membranes at least 10 α-chains and one β-chain creating
homo- and heterodimers
S-100 β-chain mainly found in Melanocytes Glial cells Langerhans’ cells / interdigitating reticulum cells Fat cells Myoepithelial cells Polyclonal antibodies primarily detects the β-chain
![Page 62: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/62.jpg)
S-100 protein
chondrocytesbrain
![Page 63: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/63.jpg)
Tonsil
S-100 protein
![Page 64: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/64.jpg)
S-100 protein – pancreas
![Page 65: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/65.jpg)
S-100 in malignant tumours
mal. melanoma breast carcinoma
>90%+++
![Page 66: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/66.jpg)
To HIER or not..
S100B Frozen IHC
Proteolytic HIER
S-100 protein
![Page 67: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/67.jpg)
Primary panel for the unknown primary tumour
”Real” CD45 CK S-100 VIMHaemato-lymphoid neoplasms
+/(-) -/(+) -/(+) +/(-)Epithelialneoplasms - +/(-) -/+ -/+Mesothelial neoplasms - + - +Mesenchymal and neuronal neoplasms
- -/(+) -/+ +
Non-neuronal neuroepithelial neoplasms
- -/(+) + +
Germ cell neoplasms - -/+ -/+ +
![Page 68: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/68.jpg)
Vimentin
Cytoplasmic intermediate filament, 57 kDa Present in all mesenchymal cells Present in early stages of all cells, replaced by other
intermediate filaments in most non-mesenchymal cells
Coexpressed with cytokeratin in some epithelia Endometrium, renal tubules, thyroid gland …
Coexpressed with cytokeratinin some non-epithelial cells Mesothelium
![Page 69: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/69.jpg)
Vimentin in normal tissue
Normal brain
HE VIM
![Page 70: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/70.jpg)
Vimentin in carcinomas
renal cell carcinoma endometrioid carcinoma
![Page 71: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/71.jpg)
Vimentin in non-epithelial tumours
mal. mesotheliomamal. melanoma
![Page 72: IHC Classification of undifferentiated tumors – the ... · - diagnostic markers. Antibodies available - applic. in diagnostic algorithms. Methods - protocol: sensitivity, specificity,](https://reader035.fdocuments.us/reader035/viewer/2022063016/5fd584cce7d5f46fbf63114e/html5/thumbnails/72.jpg)
Mogens VybergProfessor of Clinical PathologyDirector of NordiQCAalborg University Hospital, Aalborg, Denmark
IHC Classification of undifferentiated tumors –
the primary panelThank you
for your attention